Global State of Harm Reduction 2024 Report

The Global State of Harm Reduction is the only report that provides an independent analysis of harm reduction in the world. Now in its the ninth edition, the Global State of Harm Reduction 2024 is the most comprehensive global mapping of harm reduction responses to drug use, HIV and viral hepatitis.

The Global State of Harm Reduction has always been produced through a collaborative effort between community and civil society representatives and researchers. The report includes nine regional chapters authored by experts from each region. This year’s report differs slightly from previous editions as we emphasise key regional issues and populations that continue to be neglected by harm reduction services.

Each regional chapter presents data on the availability of harm reduction services and addresses two key issues that require special attention. The report also includes three new thematic chapters focused on harm reduction for Indigenous people, people in prison and youth. We also continue to include data to map the implementation of viral hepatitis services for people who use drugs.

Top trends presented in the report include:

  • 93 countries now provide at least one needle and syringe programme (NSP), compared to 92 in 2022.
  • Opioid agonist therapy (OAT) programmes are now in 94 countries, compared to 88 in 2022 – although coverage remains varied and limited.
  • The number of countries with drug consumption rooms (DCRs) or overdose preventions centres remains very small, but it has increased from 16 to 18 since 2022. The two new countries on this list are Colombia and Sierra Leone.
  • Take-home naloxone programmes are now available in 34 countries, a slight decrease from 35 in 2022.

DPNSEE has been following the Global State of Harm Reduction reports in recent years. We have already prepared an overview of the findings of the situation in South East Europe. Here it is

To access the Report, follow this link>>>.

 

Global State of Harm Reduction 2020

Harm Reduction International, an NGO dedicated to reducing the negative health, social and legal impacts of drug use and drug policy, publishes report that provides an independent analysis of harm reduction in the world. Now in it’s the seventh edition, the Global State of Harm Reduction 2020 is the most comprehensive global mapping of harm reduction responses to drug use, HIV and viral hepatitis.

The 2020 report includes:

  • A chapter which looks at the impact of the COVID-19 pandemic and related lockdowns on the provision of harm reduction services worldwide
  • Additional thematic chapters on hepatitis C and tuberculosis
  • Examples of progress in harm reduction from across the world
  • Examples of legal and policy changes which impact harm reduction service provision
  • Foreword by Dr Tlaleng Mofokeng, United Nations Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health
  • Data on the number of people who inject drugs and the number of people in prison for drug use globally

The report can be downloaded and read in full or by chapter following this link>>>.

DPNSEE have prepared a table with information on Epidemiology of HIV and viral hepatitis, and harm reduction response in South East Europe.

The document is available in PDF format following this link>>>.

 

Global State of Harm Reduction 2019

Harm Reduction International, a leading NGO dedicated to reducing the negative health, social and legal impacts of drug use and drug policy, just published their annual The Global State of Harm Reduction biennial report. First published in 2008, it involves a coordinated effort across practitioners, academics, advocates and activists to map global data and responses to drug-related harms. The data presented here has been gathered over the course of 2019 from publicly available sources and in cooperation with our partners around the world.

It is the only report to provide an independent analysis of the state of harm reduction in the world and has become the go-to source on global harm reduction developments for researchers and advocates in our sector and beyond.

The Report indicated that:

  • Since 2018, the total number of countries implementing needle and syringe programmes (NSP) has increased by just one, from 86 to 87.
  • The re-introduction of NSPs in Bulgaria and the first NSP opening in Sierra Leone have been countered by the closure of services in Uganda.
  • No new countries have begun implementing opioid substitution therapy (OST) programmes since 2018.

We extracted the data on the situation in countries of South East Europe:

To get full information from the report, follow this link>>>

Should you find any inaccuracies, please contact Harm Reduction International at office@hri.global